United States Antimony CORP Form 4 insider transactions

Director Jon R. Marinelli acquired 12,500 shares of United States Antimony Corp. common stock for $7.45 per share.

United States Antimony Corp CFO Richard R. Isaak reported the sale of 100,000 shares of common stock at $9.75 per share.

Melissa Pagen, President & COO of BRZ at United States Antimony Corp, reported a sale of 89,004 common shares.

Lloyd Bardswich, Director and Officer at United States Antimony Corp., reported a transaction involving 59,872 shares of common stock.

United States Antimony Corp Director Blaise A. Aguirre sold 27,000 shares of common stock on March 31, 2026, under a pre-arranged 10b5-1 trading plan.

Lloyd Bardswich, a Director, EVP, and Chief Mining Engineer at United States Antimony Corp (UAMY), disposed of 82,855 shares of common stock across two transactions in late March 2026.

Director Blaise A. Aguirre reported disposing 31,712 UAMY shares over two dates, retaining 872,754 shares.

United States Antimony’s Chairman & CEO Gary C. Evans received 304,524 time-based RSUs and 308,133 performance-vested stock options on January 15, 2026 under the Amended & Restated 2023 Equity Incentive Plan.

United States Antimony Corp's President of the Antimony Division, John C. Gustavsen, received grants of restricted stock units and stock options.

United States Antimony Corp's SVP and CFO, Richard R. Isaak, has filed to dispose of 83,334 shares of common stock in March 2026.

United States Antimony Corp's Chairman and CEO, Gary C. Evans, reported the sale of 400,000 common shares in multiple transactions.

Jeffrey Russell Fink, VP and General Manager of BRZ for United States Antimony Corp (UAMY), sold 34,055 shares of common stock in late March 2026.

United States Antimony Corp. granted restricted stock units and stock options to President & COO Melissa Pagen, aligning executive incentives with long-term company performance.

UNITED STATES ANTIMONY CORP's Director and EVP, Lloyd Bardswich, was granted 73,086 restricted stock units and 92,440 stock options under the company's 2023 Equity Incentive Plan.

United States Antimony Corp. Director Jon R. Marinelli was granted 1,659 restricted stock units and 1,022 stock options as part of the company's 2023 Equity Incentive Plan.

United States Antimony Corp. VP Jeffrey Fink received new equity awards, including restricted stock units and stock options, tied to future vesting and performance.

United States Antimony Corp's SVP and CFO, Richard R. Isaak, received significant equity and stock option awards under the company's 2023 Equity Incentive Plan.

United States Antimony Corp. Director John M. Keane received new restricted stock units and stock options under the company's 2023 Equity Incentive Plan.

United States Antimony Corp. Director Michael A. McManus Jr. was granted restricted stock units and stock options under the company's 2023 Equity Incentive Plan.

United States Antimony Corp. Director Joseph A. Carrabba was granted restricted stock units and stock options under the company's 2023 Equity Incentive Plan.

United States Antimony Corp. Director Blaise A. Aguirre was granted restricted stock units and stock options under the company's 2023 Equity Incentive Plan.

Lloyd Bardswich, a Director and EVP at United States Antimony Corp, reported the sale of 40,000 shares of common stock at $6.44 per share under a 10b5-1 plan.

Jeffrey Fink, VP and General Manager BRZ of United States Antimony Corp, reported selling 10,833 shares of common stock under a Rule 10b5-1 plan.

Michael A. McManus Jr., a director and 10% owner of United States Antimony Corp, reported a planned sale of 50,000 shares of common stock under a Rule 10b5-1 plan.

Jeffrey Russell Fink, VP and General Manager BRZ of United States Antimony Corp, disposed of 12,500 shares of common stock at $7.87 per share under a pre-arranged trading plan.

United States Antimony Corp's SVP and CFO, Richard R. Isaak, reported a planned disposition of 50,000 shares of common stock at $7 per share, effective October 1, 2025, under a Rule 10b5-1 plan.

UNITED STATES ANTIMONY CORP's Chairman & CEO, Gary C. Evans, has scheduled a purchase of 100,000 common shares under a Rule 10b5-1 plan.

UNITED STATES ANTIMONY CORP's Chairman & CEO, Gary C. Evans, was granted 750,000 restricted stock units and 750,000 stock options on May 27, 2025, contingent on shareholder approval of the 2023 Equity Incentive Plan.

United States Antimony Corp. executive Lloyd Bardswich received significant equity awards, including RSUs and stock options, contingent on shareholder approval of the 2023 Equity Incentive Plan.

United States Antimony Corp's CFO, Richard R. Isaak, was granted 180,000 restricted stock units and options for 200,000 shares, both contingent on shareholder approval of an amended equity plan.